Key Client Fiduciary Advisors LLC Grows Stock Holdings in CVS Health Co. (NYSE:CVS)

Key Client Fiduciary Advisors LLC lifted its stake in CVS Health Co. (NYSE:CVS) by 12.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,182 shares of the pharmacy operator’s stock after acquiring an additional 795 shares during the period. Key Client Fiduciary Advisors LLC’s holdings in CVS Health were worth $452,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Steph & Co. lifted its holdings in shares of CVS Health by 192.0% in the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares in the last quarter. Kapitalo Investimentos Ltda bought a new position in CVS Health in the 4th quarter valued at $36,000. Crewe Advisors LLC bought a new position in shares of CVS Health in the first quarter worth $40,000. Retirement Group LLC boosted its stake in CVS Health by 54.3% during the first quarter. Retirement Group LLC now owns 517 shares of the pharmacy operator’s stock valued at $41,000 after buying an additional 182 shares during the period. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health in the 3rd quarter valued at about $33,000. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CVS shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. Wells Fargo & Company raised their price target on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Evercore ISI upped their target price on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a report on Tuesday, October 8th. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $59.00 to $85.00 in a report on Friday, October 4th. Finally, Barclays upgraded CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $63.00 to $82.00 in a research note on Thursday, October 10th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $75.26.

CVS Health Stock Performance

CVS traded down $3.33 during mid-day trading on Friday, reaching $60.34. 42,250,233 shares of the company traded hands, compared to its average volume of 11,228,169. The stock has a market capitalization of $75.75 billion, a P/E ratio of 10.61, a P/E/G ratio of 0.93 and a beta of 0.54. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83. The company’s fifty day moving average price is $59.80 and its 200-day moving average price is $60.62.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.21 earnings per share. On average, sell-side analysts expect that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 4.41%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is presently 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.